Clinical Dynamix
The Chief Medical Officer serves as a strategic partner to the CEO, leading the company's preclinical through clinical pipeline and overseeing the drug development portfolio. This executive role is responsible for clinical development, regulatory strategy, and representing the company with regulatory agencies, investors, and scientific communities.
Clinical Dynamix matches exceptional talent with cutting-edge companies focused in: Pharmaceutical, Biotechnology, Medical Device/Diagnostics & Gene Therapy
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Clinical Dynamix.
Clinical Dynamix didn’t post a salary, so this is our estimate from similar listings.
3% above the average for this role
Senior Medical Director, Clinical Development Leader - GI
Alfasigma
Vice President, Regulatory Affairs
Contraline
Chief Medical Officer
TwoStep Therapeutics
Chief Medical Officer; CNS (full-time and part-time)
Sejelas_jobs
Executive Director, Clinical Development
Travere Therapeutics
Regulatory Affairs Manager
Integrated Resources INC